SARS-CoV-2 and COVID-19 Research
SARS-CoV-2 and COVID-19 Research is a research topic within Infectious Diseases. Science Explorer counts 48k research works in it since 1950. 22.9% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research related to the coronavirus disease 2019 (COVID-19), including topics such as SARS-CoV-2, vaccine development, spike protein structure, antibody responses, viral mutations, and immune protection. The papers cover various aspects of the pandemic, from virus transmission to potential therapeutic targets.
- SARS-CoV-2
- coronavirus
- vaccine
- spike protein
- antibody
- pandemic
- immunity
- mutation
- ACE2 receptor
- viral transmission
- Research works
- 48k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 22.9% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +1451% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead SARS-CoV-2 and COVID-19 Research research?
By volume, the United States and China publish the most (4.6k and 2.3k works in 2022–2025).
By volume, 2022–2025
- 1 United States 4.6k works
- 2 China 2.3k works
- 3 India 1.6k works
- 4 Italy 959 works
- 5 United Kingdom 936 works
- 6 Japan 788 works
- 7 Germany 749 works
- 8 Canada 592 works
- 9 Spain 577 works
- 10 Iran 575 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead SARS-CoV-2 and COVID-19 Research research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most SARS-CoV-2 and COVID-19 Research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Johns Hopkins University.
By volume, 2022–2025
- 1 University of North Carolina at Chapel Hill United States 162 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical College China 69 works
- 3 Johns Hopkins University United States 69 works
- 4 Harvard University United States 69 works
- 5 University of Hong Kong Hong Kong 63 works
- 6 University of Oxford United Kingdom 57 works
- 7 Tehran University of Medical Sciences Iran 53 works
- 8 Fundação Oswaldo Cruz Brazil 52 works
- 9 National Institutes of Health United States 45 works
- 10 Inserm France 44 works
Who are the leading researchers in SARS-CoV-2 and COVID-19 Research?
The most-cited researchers publishing on SARS-CoV-2 and COVID-19 Research include John P. A. Ioannidis and Aziz Sheikh.
- 1 John P. A. Ioannidis 8k citations
- 2 Aziz Sheikh 5.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is SARS-CoV-2 and COVID-19 Research research done?
The largest centres of SARS-CoV-2 and COVID-19 Research research in 2022–2025 are Beijing (China), London (United Kingdom), New York (United States) and Tehran (Iran). Among places with at least 20 works in it, it is an unusually large share of all research in De Bilt.
Largest cities, 2022–2025
Where it is the local speciality
- De BiltNL · 20.9 works20×
Location quotient: how much more of its research is in SARS-CoV-2 and COVID-19 Research than the world average.
Where is the best place to study SARS-CoV-2 and COVID-19 Research?
Among universities, judged by research, London School of Hygiene & Tropical Medicine, The University of Texas Medical Branch at Galveston and Weill Cornell Medical College in Qatar score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | London School of Hygiene & Tropical Medicine United Kingdom | 66.6 | 41.9% | 9.4× | 31 | +63.8% |
| 2 | The University of Texas Medical Branch at Galveston United States | 57.7 | 42.5% | 8.2× | 31 | +84.2% |
| 3 | Weill Cornell Medical College in Qatar Qatar | 55.4 | 37.0% | 13.6× | 10 | — |
| 4 | Duke-NUS Medical School Singapore | 49.6 | 27.6% | 8.9× | 14 | — |
| 5 | University of Hong Kong Hong Kong | 48.2 | 35.4% | 3.4× | 63 | +1.8% |
| 6 | Medical University of Vienna Austria | 48.0 | 30.3% | 4.4× | 29 | +130.5% |
| 7 | National University Health System Singapore | 44.2 | 34.9% | 6.6× | 10 | — |
| 8 | Imperial College London United Kingdom | 42.9 | 38.0% | 2.1× | 42 | +29.5% |
| 9 | Johns Hopkins University United States | 42.6 | 32.0% | 3.0× | 69 | +18.0% |
| 10 | Harvard University United States | 42.1 | 30.9% | 2.5× | 69 | +14.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is SARS-CoV-2 and COVID-19 Research research growing?
Output in 2018–2022 was 1451% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are SARS-CoV-2 and COVID-19 Research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.